These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 21741310)

  • 1. The role of TLRs in neutrophil activation.
    Prince LR; Whyte MK; Sabroe I; Parker LC
    Curr Opin Pharmacol; 2011 Aug; 11(4):397-403. PubMed ID: 21741310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1-neutrophil interactions trigger neutrophil activation and Toll-like receptor expression.
    Giraldo DM; Hernandez JC; Velilla P; Urcuqui-Inchima S
    Immunol Res; 2016 Feb; 64(1):93-103. PubMed ID: 26350266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis.
    Goh FG; Midwood KS
    Rheumatology (Oxford); 2012 Jan; 51(1):7-23. PubMed ID: 21984766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammasomes, Autophagy, and Cell Death: The Trinity of Innate Host Defense against Intracellular Bacteria.
    Krakauer T
    Mediators Inflamm; 2019; 2019():2471215. PubMed ID: 30728749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophils to the ROScue: Mechanisms of NADPH Oxidase Activation and Bacterial Resistance.
    Nguyen GT; Green ER; Mecsas J
    Front Cell Infect Microbiol; 2017; 7():373. PubMed ID: 28890882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The innate immune system, toll-like receptors and dermal wound healing: A review.
    Portou MJ; Baker D; Abraham D; Tsui J
    Vascul Pharmacol; 2015 Aug; 71():31-6. PubMed ID: 25869514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DAMPening inflammation by modulating TLR signalling.
    Piccinini AM; Midwood KS
    Mediators Inflamm; 2010; 2010():. PubMed ID: 20706656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAGE and TLRs: relatives, friends or neighbours?
    Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
    Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the innate immune system in atherosclerotic disease.
    Oude Nijhuis MM; van Keulen JK; Pasterkamp G; Quax PH; de Kleijn DP
    Curr Pharm Des; 2007; 13(10):983-94. PubMed ID: 17430162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptors and kidney diseases.
    Eleftheriadis T; Lawson BR
    Inflamm Allergy Drug Targets; 2009 Jul; 8(3):191-201. PubMed ID: 19601879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors: role of inflammation and commensal bacteria.
    Imani Fooladi AA; Mousavi SF; Seghatoleslami S; Yazdani S; Nourani MR
    Inflamm Allergy Drug Targets; 2011 Jun; 10(3):198-207. PubMed ID: 21428911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival.
    Radsak MP; Salih HR; Rammensee HG; Schild H
    J Immunol; 2004 Apr; 172(8):4956-63. PubMed ID: 15067076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus-Associated Immune Complexes Activate Human Neutrophils in an FcγRIIA-Dependent but TLR-Independent Response.
    Bonegio RG; Lin JD; Beaudette-Zlatanova B; York MR; Menn-Josephy H; Yasuda K
    J Immunol; 2019 Feb; 202(3):675-683. PubMed ID: 30610165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Innate immunity: cutaneous expression of Toll-like receptors].
    Musette P; Auquit Auckbur I; Begon E
    Med Sci (Paris); 2006 Feb; 22(2):149-52. PubMed ID: 16457754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like Receptors in the Vascular System: Sensing the Dangers Within.
    Goulopoulou S; McCarthy CG; Webb RC
    Pharmacol Rev; 2016 Jan; 68(1):142-67. PubMed ID: 26721702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR signaling and effector functions are intact in XLA neutrophils.
    Marron TU; Rohr K; Martinez-Gallo M; Yu J; Cunningham-Rundles C
    Clin Immunol; 2010 Oct; 137(1):74-80. PubMed ID: 20634142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.
    Kumar V
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107087. PubMed ID: 33075714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.
    Sun L; Liu W; Zhang LJ
    J Immunol Res; 2019; 2019():1824624. PubMed ID: 31815151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease.
    Zitzer NC; Garzon R; Ranganathan P
    Front Immunol; 2018; 9():2561. PubMed ID: 30455702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression and roles of Toll-like receptors in the biology of the human neutrophil.
    Parker LC; Whyte MK; Dower SK; Sabroe I
    J Leukoc Biol; 2005 Jun; 77(6):886-92. PubMed ID: 15728244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.